PEMERIKSAAN - DPL
PENUNJANG - SGOT, SGPT
- Gula Darah Puasa
- Elektrolit (Na, K, Ca)
- PT aPTT
- Gamma Glutamil Transpeptidase (GGT)
- Tes Toleransi Glukosa Oral
- Kolesterol Total, LDL, HDL, Trigliserida
- Hepatitis Marker
- Asam Urat
- IgA serum
- TSH FT4
- Laktat serum
- Ferritin
- α1 Antitripsin
- USG Abdomen
- MRI Abdomen
- Fibroscan
- Biopsi hati (Level of evidence 1B)
KRITERIA DIAGNOSIS Diagnosis ditegakkan berdasarkan anamnesis, pemeriksaan fisik,
dan pemeriksaan penunjang.
DIAGNOSIS KERJA Non Alcoholic Fatty Liver
DIAGNOSA BANDING
TERAPI - Vitamin E 600-800 IU/hari (Level of evidence 1B)
- Asam lemak omega 3 untuk mengobati hipertrigliseridemia
(Level of evidence 1B)
o BB < 40 kg = 450 mg/hari
o BB 40-60 kg = 900 mg/hari
o BB > 60 Kg = 1300 mg/hari
- Statin untuk mengobati dislipidemia (Level of evidence 1B)
- Asam Ursodeoksikolik tidak direkomendasikan (Level of
evidence 1B)
- Metformin tidak direkomendasikan (Level of evidence 1A)
EDUKASI - Modifikasi gaya hidup (Level of evidence 2B)
- Mengurangi berat badan 3-10% (Level of evidence 1B)
- Olahraga 30 menit - 1 jam/hari 2-3 kali seminggu selama 6-
12 minggu (Level of evidence 1B)
LAMA PERAWATAN
PROGNOSIS Tergantung penyulit
TINGKAT EVIDENS I, II
TINGKAT REKOMENDASI A, B
INDIKATOR MEDIS
KEPUSTAKAAN 1. Yang M, Gong S, Qing S, Lyman B, Geng L, Chen P et
al. Non alcoholic fatty liver disease in children : focus on
nutritional intervenstions. Nutrients. 2014;6: 4691-705
2. Vejro P, Lenta S, Socha P, Dhawan A, McKiernan P,
Baumann U et al. Diagnosis of non alcoholic fatty liver in
children and adolescent : position paper of the
ESPGHAN hepatology committee. JPGN 2012;54: 700-
13
3. Chalasani N, Younossi Z, Lavine JE. The diagnosis and
management of nonalcoholic fatty liver disease: practice
guideline by the American Association for the Study of
Liver Disease, American College of Gastroenterology,
and the American Gastroenterological Association.
Hepatology. 2012;55: 2005-23
4. Janczyk W, Lebensztejn D, Wierzbicka A, Mazur A,
Neuhoff J, Matusik P, Socha P. Omega 3 fatty acids
therapy in children with nonalcoholic fatty liver disease: a
randomized controlled trial. J Pediatr. 2015;5:2-6
Seksi SPO,
Kebijakan dan
Document Control